Thymosin Alpha-1 (TA-1) is a 28-amino acid synthetic peptide originally isolated from thymic tissue, known for its role in immune system modulation. It has been studied for its potential to enhance T-cell activation, support cytokine regulation, and improve host defense mechanisms against infections and immune dysregulation.
Research on TA-1 has also explored its possible benefits in chronic inflammation, cancer immunotherapy, and vaccine adjuvant models due to its ability to influence both innate and adaptive immune responses.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
